Fulgent Genetics, Inc.

FLGT Nasdaq CIK: 0001674930

Company Information

Industry Services-Medical Laboratories
SIC Code 8071
Entity Type operating
SEC Category Accelerated filer
State of Incorporation DE
Business Address 4399 SANTA ANITA AVE, EL MONTE, CA, 91731
Mailing Address 4399 SANTA ANITA AVE, EL MONTE, CA, 91731
Phone 626-350-0537
Fiscal Year End 1231
EIN 812621304

Financial Overview

FY2024

$1.22B
Total Assets
$1.14B
Stockholders' Equity

Recent SEC Filings

Form Type Date Filed Document
SCHEDULE 13G/A Passive ownership amendment February 4, 2026 View on SEC
4 Insider stock transaction report January 28, 2026 View on SEC
4 Insider stock transaction report January 28, 2026 View on SEC
4 Insider stock transaction report January 28, 2026 View on SEC
8-K Current report of material events December 22, 2025 View on SEC
4 Insider stock transaction report December 3, 2025 View on SEC
4 Insider stock transaction report December 3, 2025 View on SEC
4 Insider stock transaction report December 3, 2025 View on SEC
4 Insider stock transaction report December 1, 2025 View on SEC
4 Insider stock transaction report December 1, 2025 View on SEC

Insider Trading

SELL 2 insiders 7 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 8071)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.